Medication errors have occurred involving LAMICTAL.
To reduce the potential for medication errors, please write and say "LAMICTAL" clearly.


IMPORTANT NOTE: Medication errors have occurred between LAMICTAL and other medications, most commonly Lamisil®,* lamivudine, Ludiomil®,* labetalol, and Lomotil®.* Patients who do not receive LAMICTAL would be inadequately treated and could experience serious consequences. Conversely, patients erroneously receiving LAMICTAL, especially high initial doses, would be unnecessarily subjected to a risk of serious side effects.

*Lamisil (terbinafine HCl tablets) and Ludiomil (maprotiline HCl) are registered trademarks of Novartis Pharmaceuticals Corporation. Lomotil (diphenoxylate HCl, atropine sulfate) is a registered trademark of G.D. Searle LLC.



LAMICTAL is available in multiple tablet strengths




Complete Prescribing Information for LAMICTAL

This site is intended for US healthcare professionals only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us